Could Covid Drugs Help Cure Financial Ills At Ascletis Pharma? (undefined:ASCLF)

Ascletis Pharma (ASCLF) is ready to put its new Covid drug into clinical trials, but the firm is lagging in the race to bring similar medicines to market. Read more.

Related Keywords

China ,Huahai ,Gansu ,Japan ,Dongxing ,Jilin ,United States ,Hong Kong ,Japanese ,Chinese ,Junshi Bioscience ,Brii Biosciences ,Junshi Biosciences ,Covid Rdrp ,Ascletis Pharma ,Drug Administration ,Merck Co ,Ascletis Pharma Inc ,Pfizer ,China National Medical Products Administration ,Kintor Pharmaceuticals ,Hong Kong Stock Exchange ,Tandon Health ,Simcere Pharmaceutical ,Kingmed Diagnostics ,Kintor Pharmaceutical ,Everest Medicines ,National Medical Products Administration ,Genuine Biotech ,Huahai Pharmaceutical ,Apeloa Pharmaceutical ,Fosun Pharmaceutical ,